T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOW
2776
DELISTED
WideOpenWest
WOW
| $80K | ﹤0.01% |
14,616
| – | – |
|
2777
Alto Ingredients
ALTO
$330M
| $79K | ﹤0.01% |
54,700
+25,100
| +85% | +$43.4K |
|
2778
RUM Group Inc
RUM
$3.82B
| $77K | ﹤0.01% |
13,700
| – | – |
|
2779
Sutro Biopharma
STRO
$358M
| $77K | ﹤0.01% |
2,626
+823
| +46% | +$32.5K |
|
|
GTHX
2780
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $77K | ﹤0.01% |
33,732
+15,977
| +90% | +$61K |
|
2781
Sight Sciences
SGHT
$463M
| $76K | ﹤0.01% |
+11,271
| New | +$66.6K |
|
2782
Solid Power
SLDP
$536M
| $76K | ﹤0.01% |
45,535
+3,849
| +9% | +$6.64K |
|
|
EGRX
2783
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $75K | ﹤0.01% |
13,300
-2,448
| -16% | -$10.7K |
|
2784
AerSale
ASLE
$272M
| $74K | ﹤0.01% |
+10,612
| New | +$76K |
|
|
BGFV
2785
DELISTED
Big 5 Sporting Goods
BGFV
| $74K | ﹤0.01% |
24,800
+3,891
| +19% | +$12.8K |
|
|
INZY
2786
DELISTED
Inozyme Pharma
INZY
| $74K | ﹤0.01% |
16,370
+2,148
| +15% | +$10.4K |
|
2787
PDS Biotechnology
PDSB
$13.3M
| $73K | ﹤0.01% |
24,900
+7,361
| +42% | +$23.6K |
|
|
PRPH
2788
DELISTED
ProPhase Labs
PRPH
| $73K | ﹤0.01% |
1,730
| – | – |
|
2789
Custom Truck One Source
CTOS
$2.42B
| $72K | ﹤0.01% |
16,395
| – | – |
|
|
GAN
2790
DELISTED
GAN Ltd
GAN
| $72K | ﹤0.01% |
48,300
| – | – |
|
2791
BARK
BARK
$95.5M
| $71K | ﹤0.01% |
1,961
| – | – |
|
2792
Butterfly Network
BFLY
$2.47B
| $71K | ﹤0.01% |
83,400
-40,984
| -33% | -$38.3K |
|
2793
KULR Technology Group
KULR
$142M
| $71K | ﹤0.01% |
22,538
+11,563
| +105% | +$41.4K |
|
2794
Viemed Healthcare
VMD
$355M
| $71K | ﹤0.01% |
10,722
+512
| +5% | +$3.86K |
|
2795
CorMedix
CRMD
$619M
| $70K | ﹤0.01% |
16,081
+1,446
| +10% | +$7.35K |
|
2796
Microvast
MVST
$333M
| $70K | ﹤0.01% |
154,200
-111,117
| -42% | -$49.9K |
|
2797
Comtech Telecommunications
CMTL
$51.8M
| $69K | ﹤0.01% |
22,443
-8,554
| -28% | -$20.3K |
|
|
OLPX
2798
DELISTED
Olaplex Holdings
OLPX
| $69K | ﹤0.01% |
44,462
+13,505
| +44% | +$21.5K |
|
2799
Seer Inc
SEER
$117M
| $69K | ﹤0.01% |
40,900
-18,680
| -31% | -$34.9K |
|
2800
Kartoon Studios
TOON
$38.4M
| $69K | ﹤0.01% |
66,240
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.